G. Zampa

690 total citations
41 papers, 361 citations indexed

About

G. Zampa is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. Zampa has authored 41 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 17 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. Zampa's work include Bladder and Urothelial Cancer Treatments (16 papers), Colorectal Cancer Treatments and Studies (9 papers) and Cancer Treatment and Pharmacology (8 papers). G. Zampa is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Colorectal Cancer Treatments and Studies (9 papers) and Cancer Treatment and Pharmacology (8 papers). G. Zampa collaborates with scholars based in Italy, Malaysia and United States. G. Zampa's co-authors include Savino M. Di Stasi, L. Storti, Giovanni Capelli, A. Giurioli, Marco Valenti, Giuseppe Vespasiani, Robert Stephen, Antonella Giannantoni, F. Attisani and Teresa Gamucci and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

G. Zampa

40 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Zampa Italy 9 223 110 104 49 41 41 361
Felix M. Brown United States 7 205 0.9× 70 0.6× 33 0.3× 43 0.9× 46 1.1× 7 283
M. Babjuk Czechia 14 352 1.6× 90 0.8× 106 1.0× 94 1.9× 28 0.7× 28 478
Tatsuro Murase Japan 8 206 0.9× 61 0.6× 75 0.7× 52 1.1× 28 0.7× 23 315
Thomas A. Longo United States 11 185 0.8× 178 1.6× 46 0.4× 81 1.7× 18 0.4× 23 425
A P van der Meijden Netherlands 6 573 2.6× 82 0.7× 242 2.3× 49 1.0× 52 1.3× 10 643
Soloway Ms United States 11 212 1.0× 59 0.5× 80 0.8× 57 1.2× 22 0.5× 24 331
Kota Iida Japan 11 228 1.0× 165 1.5× 37 0.4× 116 2.4× 28 0.7× 38 441
Ruth Knüchel‐Clarke Germany 11 130 0.6× 74 0.7× 44 0.4× 51 1.0× 21 0.5× 39 283
Hugh Mostafid United Kingdom 8 274 1.2× 69 0.6× 85 0.8× 79 1.6× 18 0.4× 26 345
Armine K. Smith United States 9 424 1.9× 90 0.8× 171 1.6× 73 1.5× 33 0.8× 27 541

Countries citing papers authored by G. Zampa

Since Specialization
Citations

This map shows the geographic impact of G. Zampa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Zampa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Zampa more than expected).

Fields of papers citing papers by G. Zampa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Zampa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Zampa. The network helps show where G. Zampa may publish in the future.

Co-authorship network of co-authors of G. Zampa

This figure shows the co-authorship network connecting the top 25 collaborators of G. Zampa. A scholar is included among the top collaborators of G. Zampa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Zampa. G. Zampa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moscetti, Luca, Lucia Mentuccia, Patrizia Vici, et al.. (2017). ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study. Future Oncology. 13(17). 1517–1525. 4 indexed citations
2.
Sini, Valentina, Alessandra Cassano, Domenico Corsi, et al.. (2016). Bevacizumab as First-Line Treatment in HER2-Negative Advanced Breast Cancer: Pros and Cons. Tumori Journal. 102(5). 472–480. 13 indexed citations
4.
Grande, Roberta, Clara Natoli, Ida Pavese, et al.. (2016). Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis. PLoS ONE. 11(7). e0157751–e0157751. 14 indexed citations
5.
Vici, Patrizia, Laura Pizzuti, Teresa Gamucci, et al.. (2014). Non-Pegylated Liposomal Doxorubicin-Cyclophosphamide in Sequential Regimens with Taxanes as Neoadjuvant Chemotherapy in Breast Cancer Patients. Journal of Cancer. 5(6). 398–405. 6 indexed citations
6.
Gamucci, Teresa, Luca Moscetti, Lucia Mentuccia, et al.. (2013). Optimal tolerability and high efficacy of a modified schedule of lapatinib–capecitabine in advanced breast cancer patients. Journal of Cancer Research and Clinical Oncology. 140(2). 221–226. 8 indexed citations
7.
Grande, Roberta, Domenico Corsi, Raffaello Mancini, et al.. (2013). Evaluation of Relapse-Free Survival in T3N0 Colon Cancer: The Role of Chemotherapy, a Multicentric Retrospective Analysis. PLoS ONE. 8(12). e80188–e80188. 8 indexed citations
8.
Natoli, Clara, Patrizia Vici, Isabella Sperduti, et al.. (2013). Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer. Journal of Cancer Research and Clinical Oncology. 139(7). 1229–1240. 7 indexed citations
9.
Brausi, Maurizio, et al.. (2010). Single preoperative intravesical instillation of electromotive mitomycin-c for primary non-muscle invasive bladder cancer: a prospective randomized trial.. Anticancer Research. 30(4). 1424–1424. 1 indexed citations
10.
Stasi, Savino M. Di, et al.. (2010). Single preoperative intravesical instillation of electromotive mitomycin-C for primary non-muscle-invasive bladder cancer: A prospective randomized trial.. Journal of Clinical Oncology. 28(15_suppl). 4543–4543. 1 indexed citations
12.
Stasi, Savino M. Di, L. Storti, A. Giurioli, et al.. (2008). CARCINOMA IN SITU OF THE BLADDER: LONG-TERM RESULTS OF A RANDOMISED PROSPECTIVE STUDY COMPARING INTRAVESICAL ELECTROMOTIVE MITOMYCIN-C, PASSIVE DIFFUSION MITOMYCIN-C AND BACILLUS CALMETTE-GUERIN. European Urology Supplements. 7(3). 180–180. 3 indexed citations
13.
Zampa, G., et al.. (2008). Prolonged control of bone metastases in non-small-cell lung cancer patients treated with gefitinib. Lung Cancer. 60(3). 452–454. 10 indexed citations
14.
Zampa, G.. (2007). Targeting the therapy: Octreotide in thymoma relapse. Journal of Clinical Oncology. 25(18_suppl). 18199–18199. 2 indexed citations
15.
Stasi, Savino M. Di, Antonella Giannantoni, A. Giurioli, et al.. (2005). Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial. The Lancet Oncology. 7(1). 43–51. 200 indexed citations
16.
Stasi, Savino M. Di, Antonella Giannantoni, L. Storti, et al.. (2005). Quality of life after radical prostatectomy or external beam radiotherapy for localized prostate cancer: A controlled prospective study. Journal of Clinical Oncology. 23(16_suppl). 4555–4555. 1 indexed citations
17.
Stasi, Savino M. Di, Antonella Giannantoni, Robert Stephen, et al.. (2004). 280: Sequential Intra Vesical Bacillus Calmette Guerin and Electromotive Mitomycin-C for High Risk Superficial Bladder Cancer: A Prospective Controlled Study. The Journal of Urology. 171(4S). 74–74. 1 indexed citations
18.
Stasi, Savino M. Di, Antonella Giannantoni, R.L. Stephen, et al.. (2004). Sequential Bacillus Calmette Guèrin and electromotive mitomycin-C versus Bacillus Calmette Guèrin alone for high-risk superficial bladder cancer: A prospective controlled study. Journal of Clinical Oncology. 22(14_suppl). 4539–4539. 1 indexed citations
19.
Illiano, Anna, Emiddio Barletta, Valeria De Marino, et al.. (2001). New triplet chemotherapy combination with carboplatin, paclitaxel and gemcitabine plus amifostine support in advanced non small cell lung cancer: a phase II study.. PubMed. 20(5C). 3999–4003. 10 indexed citations
20.
Gamucci, Teresa & G. Zampa. (1980). Cardiotoxicity of 5-Fluorouracil. Tumori Journal. 66(5). 635–636. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026